TABLE 3.
Current status of academic research on the function and regulation of platelets in cancer therapy.
| Interventions | Clinical registries | Status | Study results | Conditions | Study start | Study completion | Reference |
|---|---|---|---|---|---|---|---|
| Diagnostic test: mRNA expression | NCT05493878 | Not yet recruiting | No results available | Pancreatic and biliary tract cancer | 2023‐03 (estimated) | 2024‐05 (estimated) | None |
| Diagnostic test: mRNA expression | GZR2017‐186 | Completed | No results available | Non‐small‐cell lung cancer | Not reported | 2017 (actual) | 182 |
| Biological: A single 2 mL heparinized peripheral blood | NCT02758678 | Completed | No results available | Lung cancer | 2015‐11 (actual) | 2016‐10 (actual) | None |
| Biological: Blood samples containing K2‐EDTA | 42763‐CRINF‐1034 CESC | Completed | No results available | Colorectal cancer | Not reported | 204 | |
|
Drug: Plavix Drug: Aspirin |
NCT00263211 | Terminated | Has results | Breast neoplasms | 2006‐01 (actual) | 2009‐09 (actual) | None |
| Diagnostic test: Platelet count | NCT02211677 | Recruiting | No results available | Nasopharyngeal carcinoma | 2014‐08 (actual) | 2024‐12 (estimated) | None |
|
Drug: Pembrolizumab Drug: Clopidogrel Drug: Acetylsalicylic acid |
NCT03245489 | Recruiting | No results available | Recurrent or metastatic squamous cell carcinoma of the head and neck | 2017‐10‐20 (actual) | 2023‐12‐31 (estimated) | None |